1. Home
  2. HROW vs MXL Comparison

HROW vs MXL Comparison

Compare HROW & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$41.34

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$15.55

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
MXL
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
HROW
MXL
Price
$41.34
$15.55
Analyst Decision
Strong Buy
Buy
Analyst Count
8
7
Target Price
$68.86
$20.25
AVG Volume (30 Days)
716.4K
1.1M
Earning Date
11-10-2025
10-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,042,000.00
$423,372,000.00
Revenue This Year
$43.92
$30.59
Revenue Next Year
$41.22
$18.41
P/E Ratio
N/A
N/A
Revenue Growth
47.83
7.53
52 Week Low
$20.85
$8.35
52 Week High
$50.72
$25.73

Technical Indicators

Market Signals
Indicator
HROW
MXL
Relative Strength Index (RSI) 58.85 55.47
Support Level $36.95 $12.87
Resistance Level $41.24 $16.00
Average True Range (ATR) 2.64 0.73
MACD 0.52 0.25
Stochastic Oscillator 89.48 86.38

Price Performance

Historical Comparison
HROW
MXL

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: